Back to Search
AZIM LALANI, MD
MD
Family Medicine Physician
NPI: 1649455601IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
4301085736(MI)ME 103943(FL)
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
4301085736(MI)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
OTHER
Class of 2002
Research & Publications (18)
The interobserver reliability of classification systems for radial head fractures: the Hotchkiss modification of the Mason classification and the AO classification systems.
PMID 19680511·Can J Surg·2009
8-other
Predictors of major intervention in infants with bronchiolitis.
PMID 19283838·Pediatr Pulmonol·2009
8-other
The hypoxia-activated ProDrug AQ4N penetrates deeply in tumor tissues and complements the limited distribution of mitoxantrone.
PMID 19176397·Cancer Res·2009
7-preclinical
A phase 1 open-label, accelerated dose-escalation study of the hypoxia-activated prodrug AQ4N in patients with advanced malignancies.
PMID 18981010·Clin Cancer Res·2008
3-trial
A single versus multiple doses of dexamethasone in infants wheezing for the first time.
PMID 18668692·Pediatr Pulmonol·2008
4-observational
C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer: results from the ASCENT trial.
PMID 18428198·Cancer·2008
4-observational
Hypoxia-selective targeting by the bioreductive prodrug AQ4N in patients with solid tumors: results of a phase I study.
PMID 18281542·Clin Cancer Res·2008
3-trial
Evaluation of the utility of radiography in acute bronchiolitis.
PMID 17382126·J Pediatr·2007
4-observational
Selective tumor targeting by the hypoxia-activated prodrug AQ4N blocks tumor growth and metastasis in preclinical models of pancreatic cancer.
PMID 17404106·Clin Cancer Res·2007
7-preclinical
Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy.
PMID 17121902·Clin Cancer Res·2006
7-preclinical
AAV serotype 8-mediated gene delivery of a soluble VEGF receptor to the CNS for the treatment of glioblastoma.
PMID 16580881·Mol Ther·2006
7-preclinical
Inhibition of lymphogenous metastasis using adeno-associated virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor.
PMID 16061674·Cancer Res·2005
7-preclinical
Anti-tumor efficacy of human angiostatin using liver-mediated adeno-associated virus gene therapy.
PMID 14741778·Mol Ther·2004
7-preclinical
Viral chemokine-binding proteins inhibit inflammatory responses and aortic allograft transplant vasculopathy in rat models.
PMID 15201663·Transplantation·2004
7-preclinical
Wrist buckle fractures: a survey of current practice patterns and attitudes toward immobilization.
PMID 17475098·CJEM·2003
8-other
The viral anti-inflammatory chemokine-binding protein M-T7 reduces intimal hyperplasia after vascular injury.
PMID 10841520·J Clin Invest·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2902 59TH ST W STE C
BRADENTON, FL 34209 - Phone
- (941) 877-7000
Quick Facts
- NPI
- 1649455601
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 24
- Publications
- 18
Are you this provider?
Claim Your Profile